{"id":22042,"date":"2025-04-11T16:54:26","date_gmt":"2025-04-11T20:54:26","guid":{"rendered":"https:\/\/dbv-technologies.com\/?post_type=press_releases&#038;p=22042"},"modified":"2025-04-11T16:54:37","modified_gmt":"2025-04-11T20:54:37","slug":"dbv-technologies-publie-son-form-10-k-americain-et-son-document-denregistrement-universel-2024","status":"publish","type":"press_releases","link":"https:\/\/dbv-technologies.com\/fr\/press_releases\/dbv-technologies-publie-son-form-10-k-americain-et-son-document-denregistrement-universel-2024\/","title":{"rendered":"DBV Technologies publie son \u00ab\u00a0Form 10-K\u00a0\u00bb am\u00e9ricain et son Document d\u2019Enregistrement Universel 2024"},"content":{"rendered":"\n<p>Ch\u00e2tillon, France, le 11 avril 2025<\/p>\n\n\n\n<p><strong>DBV Technologies publie son \u00ab&nbsp;Form 10-K&nbsp;\u00bb am\u00e9ricain et son Document d\u2019Enregistrement Universel 2024<\/strong><\/p>\n\n\n\n<p>DBV Technologies (Euronext : DBV \u2013 ISIN&nbsp;: FR0010417345 &#8211; Nasdaq&nbsp;: DBVT), une soci\u00e9t\u00e9 biopharmaceutique au stade clinique (la \u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb), a annonc\u00e9 aujourd&rsquo;hui que&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Les \u00e9tats financiers audit\u00e9s pour l\u2019exercice 2024 ont \u00e9t\u00e9 arr\u00eat\u00e9s par le Conseil d\u2019administration le 11 avril 2025, et que ceux-ci ne pr\u00e9sentent pas de changement par rapport aux \u00e9tats financiers non audit\u00e9s examin\u00e9s par le Conseil d\u2019administration le 23 mars et publi\u00e9s dans le communiqu\u00e9 de presse de la Soci\u00e9t\u00e9 en date du 24 mars 2025\u00a0;<br><\/li>\n\n\n\n<li>Son \u00ab\u00a0Form 10-K\u00a0\u00bb 2024 avait \u00e9t\u00e9 d\u00e9pos\u00e9 aupr\u00e8s de la Securities and Exchange Commission\u00a0(\u00ab\u00a0SEC\u00a0\u00bb) aux Etats-Unis ainsi que son document d\u2019enregistrement universel 2024 (\u00ab\u00a0DEU\u00a0\u00bb), aupr\u00e8s de l\u2019Autorit\u00e9 des March\u00e9s Financiers (AMF) en France.<br><\/li>\n<\/ul>\n\n\n\n<p>Le DEU 2024 int\u00e8gre notamment les informations suivantes :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Le Rapport Financier Annuel;<\/li>\n\n\n\n<li>Le Rapport de gestion;<\/li>\n\n\n\n<li>Le Rapport sur le Gouvernement d\u2019entreprise\u00a0;<\/li>\n\n\n\n<li>Le Descriptif du Programme de Rachat d\u2019Actions.<\/li>\n<\/ul>\n\n\n\n<p>Les documents peuvent \u00eatre consult\u00e9s sur le site internet de la Soci\u00e9t\u00e9 \u00e0 l\u2019adresse <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O3LhecZFlg7yFIHjz41CEWTatK5422QgT3EOnVYa4BoSfDEiv_89mmGrBa32S4YrM8eZxRX9Y_-g_pr9xVCWsQbZeDZuCkY6gIHwzSJ16bf5Tk108DUe89Y_YrbUcu2N\" rel=\"noreferrer noopener\" target=\"_blank\">www.dbv-technologies.com<\/a> dans la section Investisseurs. Le DEU 2024 est \u00e9galement disponible sur le site internet de l\u2019AMF (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O3LhecZFlg7yFIHjz41CEUOqXx32G1iI-A46SXFFEkHCjK3RmbKQVmHxigGdXg7wcPG3nOZuTvkM1DZRaFEYUGbHjbTNBMovlz6hCpYHnew=\" rel=\"noreferrer noopener\" target=\"_blank\">www.amf-france.org<\/a>), et le \u00ab&nbsp;Form 10-K&nbsp;\u00bb sur le site internet de la SEC (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O3LhecZFlg7yFIHjz41CEa7-Cx3qdWTIKxoYiyM4mBvkwaGqB2gWJZSdOlnumZwI88-2vRJvhe4JVJGy9QC_Iw==\" rel=\"noreferrer noopener\" target=\"_blank\">www.sec.gov<\/a>).<\/p>\n\n\n\n<p>Une version imprim\u00e9e de ces documents est \u00e9galement disponible sans frais au si\u00e8ge de la Soci\u00e9t\u00e9 \u00e0 l\u2019adresse suivante&nbsp;:107, avenue de la R\u00e9publique, 92320 Ch\u00e2tillon.<\/p>\n\n\n\n<p><strong>A propos de DBV Technologies&nbsp;<\/strong><\/p>\n\n\n\n<p>DBV Technologies est une entreprise biopharmaceutique de stade clinique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement d\u2019options de traitement des allergies alimentaires et autres affections immunologiques ayant d\u2019importants besoins m\u00e9dicaux non satisfaits. DBV Technologies se concentre actuellement sur l\u2019\u00e9tude de l\u2019utilisation de sa technologie exclusive, le patch VIASKIN<sup>\u00ae<\/sup>, pour traiter les allergies alimentaires caus\u00e9es par une r\u00e9action immunitaire hypersensible et caract\u00e9ris\u00e9es par une gamme de sympt\u00f4mes dont la gravit\u00e9 varie de l\u00e9g\u00e8re \u00e0 l\u2019anaphylaxie potentiellement mortelle. Des millions de personnes vivent avec des allergies alimentaires, y compris de jeunes enfants. Gr\u00e2ce \u00e0 l\u2019immunoth\u00e9rapie \u00e9picutan\u00e9e (EPIT\u2122), le patch VIASKIN<sup><sup>\u00ae<\/sup><\/sup>&nbsp;est con\u00e7u pour dispenser des quantit\u00e9s de microgrammes d\u2019un compos\u00e9 biologiquement actif dans le syst\u00e8me immunitaire \u00e0 travers une peau intacte. L\u2019EPIT est une nouvelle classe de traitement non invasif cherchant \u00e0 modifier l\u2019allergie sous-jacente d\u2019un individu en r\u00e9\u00e9duquant le syst\u00e8me immunitaire \u00e0 se d\u00e9sensibiliser \u00e0 l\u2019allerg\u00e8ne en tirant parti des propri\u00e9t\u00e9s de tol\u00e9rance immunitaire de la peau. DBV Technologies s\u2019est engag\u00e9e \u00e0 transformer le traitement des personnes souffrant d\u2019allergies alimentaires. Les programmes d\u2019allergie alimentaire de la Soci\u00e9t\u00e9 comprennent des \u00e9tudes cliniques en cours avec le patch VIASKIN<sup><sup>\u00ae<\/sup><\/sup>&nbsp;Peanut chez les jeunes enfants (de 1 \u00e0 3 ans) et les enfants (de 4 \u00e0 7 ans) allergiques \u00e0 l\u2019arachide.<\/p>\n\n\n\n<p>Le si\u00e8ge mondial de DBV Technologies est situ\u00e9 \u00e0 Ch\u00e2tillon, en France, avec des op\u00e9rations nord-am\u00e9ricaines bas\u00e9es \u00e0 Warren, dans le New Jersey. Les actions ordinaires de la Soci\u00e9t\u00e9 sont n\u00e9goci\u00e9es sur le segment B d\u2019Euronext Paris (DBV, code ISIN : FR0010417345) et les ADS de la Soci\u00e9t\u00e9 (chacun repr\u00e9sentant cinq actions ordinaires) sont n\u00e9goci\u00e9s sur le Nasdaq Capital Market (DBVT \u2013 CUSIP : 23306J309).<\/p>\n\n\n\n<p>Pour plus d\u2019informations, veuillez consulter&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O3LhecZFlg7yFIHjz41CEWTatK5422QgT3EOnVYa4BqkE3XlurflBXR2Q0BwyMVTQ9fY8zJpHr5M8B_U5uztEgGxTmEW_J_77kOMpIV0XnRQziwoF9paET7srUD1v4zal0aLA4uFO50pY3P41B0Dqxwop-e-9FDnbqPfQ1UlH-Q3WbIVA2ShTUHFrFyQW_LG86ZomV3UHGRJXfyCbNmisHKC58yyPWb20Hl957nYpP3BPYJhPMGQ_cq2a0GfhP0JXJQuz0TCmkeMnII7k_pxiLkYlnJfZH7JkGIexGeFgZCB1hfP7oBD0WuxR3NBbKek\" rel=\"noreferrer noopener\" target=\"_blank\">www.dbv-technologies.com<\/a>&nbsp;et nous contacter sur&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5M9GP2zZDZrxAFuOZOEH61gg8siEy6TcudC38A8A82ysxvdGwHIgKxomaJ0yEK3gaNj7AhjR5f_jt941m8zvETHUm8mRkX6mNS0EKV4aUqZc_jSbjFde_BT4T9GNsOSW9iWHxXyh8CsxeYRIAZ7yW16nSzR06C2fy2BdzoqcSzRqnrt-KCHdbsqSxbR9UsFMOk6Krr-IvO15gXSEGIgWPRJ9zpc8XlFb-a-Yvjzy_I1QMkLx5C6z6zhbOsz8ciDplg_Jq2naz3KGACGe7SaTp-L6xNR6o-9iWcktvEWEX14=\" rel=\"noreferrer noopener\" target=\"_blank\">X (formerly Twitter)<\/a>&nbsp;et&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_bWzMrRZ4_FK1tGC4D-8qCNpYz4dK2q1x2Q0N4Buc-wCJUIPiyGaAP1f9BFANWV6AWnSRUne9YCoxhmY1sVzMPAN0QRaJC-8gkLu4rvXYSQ3yltAts65Rd3jxjt4bX1bbdSi_SjN4U34A0OdJVghxCHjixyWIMoozsSSkOW6iAlH29j5hKMAXugxeY1aQxvQ8AtmICwRNZnb8Sf7G2pryP-DYh1XkYncumSdiDAOcrBMsf5pcJtjOMXEEOHTv3sEiwqdSv4hJgLhUvdRoBnjukA-pNRUQkKz8FH__OrryNE=\" rel=\"noreferrer noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n\n\n\n<p><strong>Contact avec les investisseurs<\/strong><br>Katie Matthews<br>DBV&nbsp;Technologies<br><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ipf354EVZFo1XOGNPGwXMYQqWW5xaWnj5RJIiUOsSKIpxVYhXJPGEuZGY26QtwQB2bYlaHoJolNTTCC9u4AbdTZ8nnCDTwfaqTTFnUy7o7583QRDoNn5PQgYF_-fx7Qt5YfTJEMML7XedbMlYJ2lgQ==\" rel=\"noreferrer noopener\" target=\"_blank\">katie.matthews@dbv-technologies.com<\/a><\/p>\n\n\n\n<p><strong>Contact avec les m\u00e9dias<\/strong><br>Angela Marcucci<br>DBV&nbsp;Technologies<br><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hjx9nCOXwYxPNtHe3Blg9NFyJcYfJXlptFe3sTAHIrkCtEqU3GlJTzfMs8-0B-K_aOREO1opOjTKUE4MfCmeNAQ9qkhUPQ5nz1OtAX-SVougI1bHyTaUkZdU-CAgR5NtPjUMUt9XuFcd6KDZ1-0Lew==\" rel=\"noreferrer noopener\" target=\"_blank\">angela.marcucci@dbv-technologies.com<\/a><\/p>\n\n\n\n<p id=\"gnw_attachments_section-header\"><strong>Pi\u00e8ce jointe<\/strong><\/p>\n\n\n\n<ul id=\"gnw_attachments_section-items\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E-e7r_nQYPziBSbeigIjxeH6A5-LAhbF1SeqpBTaPfQg-vQ790MKqVthdQU-wvm5BbZj2EEPkV2BAQ2F6wr-z5Q9DyI-NMV5Bw8HK9WMC8sAhBcChMLP7p8pulTWCMvoYhdHxbO2sQomVCe0QwU3xUnrDrGAZKw4RtzFm57uQkw=\" target=\"_blank\" rel=\"noreferrer noopener\">version PDF<\/a><\/li>\n<\/ul>\n\n\n\n<p><img decoding=\"async\" alt=\"\" data-src=\"https:\/\/ml-eu.globenewswire.com\/media\/NGZhNTk5NDYtN2VkZS00MWVhLWE5NjUtNmExZmJkN2VmMzQ1LTEwMTExNTItMjAyNS0wNC0xMS1mcg==\/tiny\/DBV-Technologies-S-A-.png\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\"><\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"wds_primary_press_release_type":0,"footnotes":""},"press_release_type":[47],"class_list":["post-22042","press_releases","type-press_releases","status-publish","hentry","press_release_type-amf-filing"],"acf":[],"_links":{"self":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/22042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/types\/press_releases"}],"version-history":[{"count":0,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/22042\/revisions"}],"wp:attachment":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/media?parent=22042"}],"wp:term":[{"taxonomy":"press_release_type","embeddable":true,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_release_type?post=22042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}